3.2. Liposome Preparation

AA Ariana Abawi
XW Xiaoyi Wang
JB Julien Bompard
AB Anna Bérot
VA Valentina Andretto
LG Leslie Gudimard
CD Chloé Devillard
EP Emma Petiot
BJ Benoit Joseph
GL Giovanna Lollo
TG Thierry Granjon
AG Agnès Girard-Egrot
OM Ofelia Maniti
request Request a Protocol
ask Ask a question
Favorite

Liposomes were prepared using the thin film hydration method. Briefly, lipids dissolved in chloroform with a total lipid mass of 5 mg were mixed in a round flask. The solvent was dried under vacuum at 50 °C on a rotatory evaporator. The lipid film obtained was hydrated with 1 mL of sterile PBS, while stirring and heated above the lipid melting point. This resulted in the formation of MultiLamellar Vesicles (MLVs) with various sizes and number of layers. Six freeze–thaw cycles in liquid nitrogen were then applied to the prepared liposomes in order to burst the MLVs into Large Unilamellar Vesicles (LUVs). The LUVs size was defined by extrusion through a porous membrane with a Mini-Extruder (Avanti Polar Lipids, Alabaster, AL, USA). Liposomes were heated above their phase-transition temperature (Tm), extruded through a 400 nm and then, a 100 nm pore diameter polycarbonate membrane using a MiniExtruder (Avanti Polar Lipids, Alabaster, AL, USA). The final liposome solution was stored at 4 °C for 4 weeks, without further extrusion.

MMAE-derivative was added to the lipid mixture in chloroform prior to drying. Liposomes containing a final concentration of 5 µM MMAE-derivative were prepared. This corresponded to 0.12% of the total lipid mass and a lipid/MMAE derivative molar ratio of 2500:1, at a molar percentage of 0.04%. Liposomes contained 20 molar % of fusogenic lipid 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) and 79.06% of phosphatidylcholine as follows 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), 1,2-dipalmitoyl-glycero-3-phosphocholine (DPPC), 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), and 1-palmitoyl-2-oleoyl-glycero-3-phosphocholine (POPC), for DS, DP, DM and PO-MMAE preparations, respectively. Detailed liposome composition is given in Table 1.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A